Evidence map›Paper›PMID 41459440›Full record

ArticleThe journal of allergy and clinical immunology. Global2026

Global variations of IgE cross-reactivity in Cupressus allergy.

Takeru Sugawara, Tingting Ma, Xueyan Wang, Neera Chakrapani, Hiroki Matsuhara, Danying Peng, Carlos Blanco, Domingo Barber, Kathrine Beck Sylvestersen, Edward G Brooks and 3 more

Abstract read
In one paragraph

Article in The journal of allergy and clinical immunology. Global, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Takeru SugawaraTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Tingting MaDepartment of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Xueyan WangDepartment of Allergy, Beijing Shijitan Hospital, Capital Medical University, Beijing, China.
Neera ChakrapaniALK-Abelló, Hørsholm, Denmark.
Hiroki MatsuharaTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Danying PengALK, Guangzhou, China.
Carlos BlancoDepartamento de Alergia, Hospital Universitario de La Princesa, Instituto de Investigación Sanitaria Princesa, Madrid, Spain.
Domingo BarberDepartamento de Ciencias Médicas Básicas, Facultad de Medicina, Instituto de Medicina Molecular Aplicada - Nemesio Díez (IMMA-ND), Universidad San Pablo-CEU, CEU Universities, Madrid, Spain.
Kathrine Beck SylvestersenALK-Abelló, Hørsholm, Denmark.
Edward G BrooksPediatric Immunology and Infectious Disease, UT Health San Antonio, University of Texas Health Science Center at San Antonio, San Antonio, Tex.
Peter Sejer AndersenALK-Abelló, Hørsholm, Denmark.
Katsuyo Ohashi-DoiTorii Pharmaceutical Co, Ltd, Tokyo, Japan.
Jens Emil Vang PetersenALK-Abelló, Hørsholm, Denmark.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: Seasonal allergic rhinitis triggered by Cupressaceae species is a significant concern worldwide, particularly in regions such as Japan, China, Spain, and the United States. Objective: This study investigated specific IgE responses to Cupressaceae species and the potential clinical relevance of cross-reactivity, focusing on Japanese cedar ( Methods: We analyzed serum samples from 609 patients across 4 countries to measure levels of specific IgE using ImmunoCAP. We assessed IgE reactivity against Cry j extract and other Cupressaceae species, including Arizona cypress and red cedar extracts, to delineate patterns of reactivity. Results: Levels of specific IgE against Cry j were markedly elevated in Japanese samples; they were nearly 10-fold higher than those against other allergens. In contrast, samples from China, Spain, and the United States showed lower levels of Cry j-specific IgE, with significant levels of reactivity against Conclusion: These findings indicate notable geographic variations in specific IgE reactivity and cross-reactivity among Cupressaceae species, thus underscoring the importance of tailoring diagnostic and therapeutic approaches in allergy treatment based on region-specific allergen exposure patterns.

Indexed as

allergy treatmentcross-reactivityCupressaceaegeographic variabilityIgE reactivityregional therapeutic approachesSeasonal allergic rhinitistailored diagnostics

Identifiers

PMID41459440
PMCPMC12743450

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.